Scribe Therapeutics


Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Employees

51-200

Links


Org chart

Hiring!

Benjamin L. Oakes
Co-Founder, President & CEO
Collapse
Brett T. Staahl
Co-Founder & VP, External Innovation
Svetlana Lucas
Chief Business Officer
Vera Switek
VP, Talent
Ed Sterling II
Director, Information Technology At Scribe Therapeutics
Jenny Malecki
Executive Assistant To Chief Executive Officer
Aarif Khakoo
Chief Scientific Officer
Andrew Meadows
Senior Director, Human Resources
Maria Mirotsou
Senior Vice President, Discovery

Board & advisors

David F. Savage
Co-Founder & Scientific Advisor
Jennifer A. Doudna
Co-Founder & Scientific Advisor